AAAAAA
Results:
1-19
|
Results: 19
Authors:
Hejna, M
Kostler, WJ
Raderer, M
Steger, GG
Brodowicz, T
Scheithauer, W
Wiltschke, C
Zielinski, CC
Citation: M. Hejna et al., Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trial, EUR J CANC, 37(16), 2001, pp. 1994-2002
Authors:
Locker, GJ
Wenzel, C
Schmidinger, M
Gnant, MFX
Marosi, C
Jakesz, R
Zielinski, CC
Steger, GG
Citation: Gj. Locker et al., Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancerpatients, ANTI-CANC D, 12(3), 2001, pp. 209-212
Authors:
Schmidinger, M
Budinsky, AC
Wenzel, C
Locker, GJ
Pluschnig, U
Brodowicz, T
Kubista, E
Maca, S
Zabernigg, A
Ilsinger, P
Seewann, L
Hojas, S
Blach, M
Zielinski, CC
Steger, GG
Citation: M. Schmidinger et al., Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial, CANC CHEMOT, 47(1), 2001, pp. 57-62
Authors:
Mader, RM
Schmidt, WM
Sedivy, R
Rizovski, B
Braun, J
Kalipciyan, M
Exner, M
Steger, GG
Mueller, MW
Citation: Rm. Mader et al., Reverse transcriptase template switching during reverse transcriptase-polymerase chain reaction: Artificial generation of deletions in ribonucleotidereductase mRNA, J LA CL MED, 137(6), 2001, pp. 422-428
Authors:
Friedl, J
Stift, A
Paolini, P
Roth, E
Steger, GG
Mader, R
Jakesz, R
Gnant, MFX
Citation: J. Friedl et al., Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer, CANC BIO R, 15(5), 2000, pp. 477-486
Authors:
Brodowicz, T
Kostler, WJ
Moslinger, R
Tomek, S
Vaclavik, I
Herscovici, V
Wiltschke, C
Steger, GG
Wein, W
Seifert, M
Kubista, E
Zielinski, CC
Citation: T. Brodowicz et al., Single-agent gemcitabine as second- and third-line treatment in metastaticbreast cancer, BREAST, 9(6), 2000, pp. 338-342
Authors:
Brodowicz, T
Wolfram, RM
Kostler, WJ
Tomek, S
Vaclavik, I
Steger, GG
Teleky, B
Fugger, R
Jakesz, R
Zielinski, CC
Citation: T. Brodowicz et al., Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer, ANTI-CANC D, 11(8), 2000, pp. 623-628
Authors:
Brodowicz, T
Koestler, WJ
Tomek, S
Vaclavik, I
Herscovici, V
Wiltschke, C
Steger, GG
Zielinski, CC
Citation: T. Brodowicz et al., Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer, ANTI-CANC D, 11(3), 2000, pp. 149-153
Authors:
Schmidinger, M
Steger, GG
Budinsky, AC
Wenzel, C
Brodowicz, T
Locker, GJ
Kramer, G
Marberger, M
Zielinski, CC
Citation: M. Schmidinger et al., Vinorelbine and interferon-alpha 2c as second-line therapy in metastatic renal cell carcinoma, ANTI-CANC D, 11(3), 2000, pp. 175-179
Authors:
Locker, GJ
Mader, RM
Steiner, B
Wenzl, E
Zielinski, CC
Steger, GG
Citation: Gj. Locker et al., Benefit of interferon-alpha(2b) in a patient with unresectable hepatoma and chronic infection with hepatitis C virus, EUR J GASTR, 12(2), 2000, pp. 251-253
Authors:
Schmidinger, M
Steger, GG
Wenzel, C
Locker, GJ
Brodowicz, T
Budinsky, AC
Wiltschke, C
Kramer, G
Marberger, M
Zielinski, CC
Citation: M. Schmidinger et al., Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial, CANCER IMMU, 49(7), 2000, pp. 395-400
Authors:
Muller, M
Bockenheimer, J
Zellenberg, U
Klein, N
Steger, GG
Eichler, HG
Mader, RM
Citation: M. Muller et al., Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patients, BREAST CANC, 60(3), 2000, pp. 211-217
Authors:
Schmidinger, M
Budinsky, AC
Wenzel, C
Piribauer, M
Brix, R
Kautzky, M
Oder, W
Locker, GJ
Zielinski, CC
Steger, GG
Citation: M. Schmidinger et al., Glutathione in the prevention of cisplatin induced toxicities - A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer, WIEN KLIN W, 112(14), 2000, pp. 617-623
Authors:
Sedivy, R
Wolf, B
Kalipciyan, M
Steger, GG
Karner-Hanusch, J
Mader, RM
Citation: R. Sedivy et al., Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequence, BR J CANC, 82(7), 2000, pp. 1276-1282
Authors:
Locker, GJ
Steger, GG
Gnant, MFX
Steiner, B
Simonitsch, I
Krainer, M
Budinsky, A
Brodowicz, T
Spitzauer, S
Jakesz, R
Zielinski, CC
Citation: Gj. Locker et al., Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?, J IMMUNOTH, 22(1), 1999, pp. 85-89
Authors:
Wenzel, C
Schmidinger, M
Locker, GJ
Taucher, S
Gnant, M
Jakesz, R
Steger, GG
Citation: C. Wenzel et al., Clinical phase II evaluation of the combination therapy with Docetaxel andEpidoxorubicin in the neoadjuvant, cytostatic treatment on patients with primary breast cancer (T1-4, N0-2, M0), WIEN KLIN W, 111(20), 1999, pp. 843-850
Authors:
Locker, GJ
Mader, RM
Rizovski, B
Knapp, S
Domanovits, H
Muellner, M
Hoeller, C
Steger, GG
Sterz, F
Freissmuth, M
Frass, M
Laggner, AN
Citation: Gj. Locker et al., Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: Hemodynamic and pharmacokinetic interactions, J PHARM EXP, 290(1), 1999, pp. 43-50
Authors:
Locker, GJ
Kapiotis, S
Veitl, M
Mader, RM
Stoiser, B
Kofler, J
Sieder, AE
Rainer, H
Steger, GG
Mannhalter, C
Wagner, OF
Citation: Gj. Locker et al., Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders, BR J HAEM, 105(4), 1999, pp. 912-919
Authors:
Mader, RM
Brunner, M
Rizovski, B
Mensik, C
Steger, GG
Eichler, HG
Muller, M
Citation: Rm. Mader et al., Analysis of microdialysates from cancer patients by capillary electrophoresis, ELECTROPHOR, 19(16-17), 1998, pp. 2981-2985
Risultati:
1-19
|